PLUS1
1,415.00
10.00 (0.71%)
10.00 (0.71%)
Upgrade to Real-Time
Market Open
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
US$29.56
|
|
Real-time Level 2 for London Stock Exchange
Monthly Subscription
for only
US$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
US$88.69
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type | Stock ISIN | Stock Description |
|---|---|---|---|---|---|
| Glaxosmithkline Plc | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Price Change % | Stock Price | Last Trade  |
|
|---|---|---|---|---|
| 10.00 | 0.71% | 1,415.00 | 01:08:15 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1,405.00 | 1,405.00 | 1,423.20 | 1,405.00 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1,414.80 | 1,415.20 | 0.40 | - | 5 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,831 | 2,741,465 | 1,416.25p | 38,826,036p | - | 1,284.00 - 1,847.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 01:08:24 | O | 200 | 1,414.912p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 69.42Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 26/1/2021 | 19:45 | Dow Jones News | Hikma Pharmaceuticals Says It Is in Talks With.. |
| 26/1/2021 | 19:28 | Alliance News |  TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt.. |
| 22/1/2021 | 18:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC FDA approves ViiV Healthcare's Cabenuva.. |
| 22/1/2021 | 17:58 | Alliance News | TOP NEWS: Glaxo, Johnson & Johnson Long-Acting HIV Drug.. |
| 21/1/2021 | 03:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 21/1/2021 | 02:50 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 21/1/2021 | 02:02 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,404.40 | 1,423.20 | 1,361.00 | 1,383.60 | 8,363,883 | 10.60 | 0.75% |
| 1 Month | 1,351.40 | 1,446.60 | 1,336.60 | 1,386.16 | 8,434,509 | 63.60 | 4.71% |
| 3 Months | 1,335.40 | 1,482.20 | 1,328.80 | 1,390.69 | 9,800,908 | 79.60 | 5.96% |
| 6 Months | 1,574.80 | 1,631.60 | 1,284.00 | 1,426.00 | 8,509,589 | -159.80 | -10.15% |
| 1 Year | 1,795.00 | 1,847.00 | 1,284.00 | 1,525.51 | 9,759,886 | -380.00 | -21.17% |
| 3 Years | 1,338.60 | 1,857.00 | 1,236.40 | 1,545.93 | 9,093,731 | 76.40 | 5.71% |
| 5 Years | 1,385.50 | 1,857.00 | 1,236.40 | 1,536.76 | 9,153,497 | 29.50 | 2.13% |
